DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/6psx2x/exelixis) has announced the addition of the "Exelixis Partnering 2009-2014" company profile to their offering.
The Partnering Agreements with Exelixis 2009-2014 report provides an in-depth insight into the partnering interests and activities of one of the worlds leading biopharma companies.
This report provides all the information you require to better understand Exelixis and its partnering interests and activities over the past seven years.
One of the key aspects of partnering is finding those companies that are potential partners for the development and commercialization of the next generation of therapies as developed by innovative biopharma R&D companies. A lot of resources are spent on finding partners, identifying their interests and making contact to initiate discussions.
Using this report, dealmakers will effectively and efficiently target their partnering activities to deliver the company's business development objectives.
Key Topics Covered:
Chapter 1 - Introduction
Chapter 2 - Biopharma top 50 and dealmaking activity
Chapter 3 - Top bigpharma deals by value
Chapter 4 - Submitting Opportunities to Prospective Partners
Chapter 5 - Forthcoming partnering events
Chapter 6 - Company Profile
For more information visit http://www.researchandmarkets.com/research/6psx2x/exelixis